Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication

Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Genetic predisposition, such as point mutations and copy number variants of the SNCA gene locus can cause very similar PD-like neurodegeneration. The impact of altered α-synuclein protein expression on integrity and developmental potential of neuronal stem cells is largely unexplored, but may have wide ranging implications for PD manifestation and disease progression. Here, we investigated if induced pluripotent stem cell-derived neuronal precursor cells (NPCs) from a patient with Parkinson’s disease carrying a genomic triplication of the SNCA gene (SNCA-Tri). Our goal was to determine if these cells these neuronal precursor cells already display pathological changes and impaired cellular function that would likely predispose them when differentiated to neurodegeneration. To achieve this aim, we assessed viability and cellular physiology in human SNCA-Tri NPCs both under normal and environmentally stressed conditions to model in vitro gene-environment interactions which may play a role in the initiation and progression of PD. Human SNCA-Tri NPCs displayed overall normal cellular and mitochondrial morphology, but showed substantial changes in growth, viability, cellular energy metabolism and stress resistance especially when challenged by starvation or toxicant challenge. Knockdown of α-synuclein in the SNCA-Tri NPCs by stably expressed short hairpin RNA (shRNA) resulted in reversal of the observed phenotypic changes. These data show for the first time that genetic alterations such as the SNCA gene triplication set the stage for decreased developmental fitness, accelerated aging, and increased neuronal cell loss. The observation of this “stem cell pathology” could have a great impact on both quality and quantity of neuronal networks and could provide a powerful new tool for development of neuroprotective strategies for PD.

[1]  Michael J. Devine,et al.  A cell culture model for monitoring α-synuclein cell-to-cell transfer , 2015, Neurobiology of Disease.

[2]  E. Cadenas,et al.  Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. , 2014, Antioxidants & redox signaling.

[3]  Michael D. Pluth,et al.  Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons , 2013, Science.

[4]  Torsten Kluba,et al.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression. , 2013, Cell stem cell.

[5]  K. Ess,et al.  Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects. , 2012, Neurotoxicology.

[6]  J. Yates,et al.  Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 , 2012, Nature.

[7]  Christine Klein,et al.  Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease , 2012, Science Translational Medicine.

[8]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[9]  B. Hyman,et al.  Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology , 2012, Nature Reviews Neuroscience.

[10]  Guang Shi,et al.  The Emerging Role of Proteolysis in Mitochondrial Quality Control and the Etiology of Parkinson's Disease , 2012, Parkinson's disease.

[11]  M. Memo,et al.  Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease , 2012, EMBO molecular medicine.

[12]  N. Naidoo,et al.  The endoplasmic reticulum stress response in aging and age-related diseases , 2012, Front. Physio..

[13]  J. Langston,et al.  Small Molecules Greatly Improve Conversion of Human-Induced Pluripotent Stem Cells to the Neuronal Lineage , 2012, Stem cells international.

[14]  A. Negro,et al.  α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions* , 2012, The Journal of Biological Chemistry.

[15]  L. Peterson,et al.  Oxidative Stress and Microglial Cells in Parkinson's Disease , 2012, Mediators of inflammation.

[16]  Timothy J. Nelson,et al.  Mitochondria in control of cell fate. , 2012, Circulation research.

[17]  S. Grimm The ER-mitochondria interface: the social network of cell death. , 2012, Biochimica et biophysica acta.

[18]  D. Steindler,et al.  Stem cell pathologies and neurological disease , 2012, Modern Pathology.

[19]  C. Cotman,et al.  Caspase-3 activation as a bifurcation point between plasticity and cell death , 2012, Neuroscience Bulletin.

[20]  Lief E. Fenno,et al.  SNCA Triplication Parkinson's Patient's iPSC-derived DA Neurons Accumulate α-Synuclein and Are Susceptible to Oxidative Stress , 2011, PloS one.

[21]  Jeffrey D. Zaremba,et al.  MEF2C Enhances Dopaminergic Neuron Differentiation of Human Embryonic Stem Cells in a Parkinsonian Rat Model , 2011, PloS one.

[22]  G. Schatten,et al.  Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts , 2011, PloS one.

[23]  Guo-qiang Lu,et al.  Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK. , 2011, Free radical biology & medicine.

[24]  D. Krainc,et al.  Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.

[25]  R. Nussbaum,et al.  Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.

[26]  G. Reiser,et al.  Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. , 2011, Antioxidants & redox signaling.

[27]  P. Blain,et al.  Mitochondrial Dysfunction in Parkinson's Disease , 2011, Parkinson's disease.

[28]  Blake Byers,et al.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.

[29]  F. Gage,et al.  Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice , 2011, Neurobiology of Disease.

[30]  C. Tanner,et al.  Rotenone, Paraquat, and Parkinson’s Disease , 2011, Environmental health perspectives.

[31]  A. Pyle,et al.  Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner. , 2011, Cell stem cell.

[32]  J. Andersen,et al.  Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo , 2010, Neuroscience Letters.

[33]  Wayne F. Patton,et al.  Novel Cell- and Tissue-Based Assays for Detecting Misfolded and Aggregated Protein Accumulation Within Aggresomes and Inclusion Bodies , 2010, Cell Biochemistry and Biophysics.

[34]  Y. Suh,et al.  Amyloid Precursor Protein Binding Protein-1 Modulates Cell Cycle Progression in Fetal Neural Stem Cells , 2010, PloS one.

[35]  J. Rehman Empowering self-renewal and differentiation: the role of mitochondria in stem cells , 2010, Journal of Molecular Medicine.

[36]  Cindy E J Dieteren,et al.  Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation. , 2010, Antioxidants & redox signaling.

[37]  Yau-Huei Wei,et al.  Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. , 2010, Biochimica et biophysica acta.

[38]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[39]  G. Hajnóczky,et al.  SR/ER-mitochondrial local communication: calcium and ROS. , 2009, Biochimica et biophysica acta.

[40]  R. Taneja,et al.  Oxidative stress regulation of stem and progenitor cells. , 2009, Antioxidants & redox signaling.

[41]  D. Freyssenet,et al.  Control of mitochondrial biogenesis, ROS level, and cytosolic Ca2+ concentration during the cell cycle and the onset of differentiation in L6E9 myoblasts. , 2009, American journal of physiology. Cell physiology.

[42]  Rudolf Jaenisch,et al.  Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.

[43]  L. Colombaioni,et al.  Mitochondrial remodeling in differentiating neuroblasts , 2009, Brain Research.

[44]  V. Bunik,et al.  α-Ketoglutarate dehydrogenase contributes to production of reactive oxygen species in glutamate-stimulated hippocampal neurons in situ , 2009, Neuroscience.

[45]  H. Brown-Borg,et al.  Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells , 2008, Neuroscience Letters.

[46]  M. Kyba,et al.  Caspase activity mediates the differentiation of embryonic stem cells. , 2008, Cell stem cell.

[47]  N. Avadhani,et al.  Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain* , 2008, Journal of Biological Chemistry.

[48]  M. Farrer,et al.  α-Synuclein and Parkinson disease susceptibility , 2007, Neurology.

[49]  N. Nukina,et al.  Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis* , 2007, Journal of Biological Chemistry.

[50]  Andre Terzic,et al.  Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells , 2007, Nature Clinical Practice Cardiovascular Medicine.

[51]  D. Beach,et al.  A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. , 2006, Antioxidants & redox signaling.

[52]  C. Mannella,et al.  Structural and functional features and significance of the physical linkage between ER and mitochondria , 2006, The Journal of cell biology.

[53]  Ronald J A Wanders,et al.  Biochemistry of mammalian peroxisomes revisited. , 2006, Annual review of biochemistry.

[54]  S. Orrenius,et al.  Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. , 2005, Biochemical and biophysical research communications.

[55]  P. Brookes,et al.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.

[56]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[57]  Gary Fiskum,et al.  Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax , 2002, Journal of neurochemistry.

[58]  P. Lebaron,et al.  Effectiveness of SYTOX Green Stain for Bacterial Viability Assessment , 1998, Applied and Environmental Microbiology.

[59]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[60]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[61]  R. Haworth,et al.  Relationship between configuration, function, and permeability in calcium-treated mitochondria. , 1976, The Journal of biological chemistry.

[62]  Hyun Min Jeon,et al.  Molecular and Cellular Pathobiology Wnt / Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism , 2012 .

[63]  Michael K Pugsley,et al.  An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. , 2011, Proceedings of the Western Pharmacology Society.

[64]  J. Langston,et al.  Mitochondrial dysfunction in skin fibroblasts from a Parkinson's disease patient with an alpha-synuclein triplication. , 2011, Journal of Parkinson's disease.

[65]  D. Wallace,et al.  Energetics, epigenetics, mitochondrial genetics. , 2010, Mitochondrion.

[66]  M. Farrer,et al.  alpha-Synuclein and Parkinson disease susceptibility. , 2007, Neurology.

[67]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.